Skip to content

Blog

Octus on Credit: European CLOs: Spreads, Supply, and Regulatory Shifts

Chris Dammers, Deputy Editor, CLOs

The CLO market on both sides of the Atlantic has regained nearly all the ground lost since late February despite elevated geopolitical risk – though new issue spreads on the European side are lagging behind with triple-As in the low to mid-130 bps area. With secondary spreads flat over the last week, the potential for further tightening seems limited and there are signs of resistance at current levels for seniors and signs of widening in price guidance for European mezz tranches. Yet investors have had enough leverage to push back on aggressive features, such as Carlyle’s attempt to bring an unusual fee structure to a European new issue.

Loan supply has picked up but margin compression is putting pressure on the CLO equity arbitrage, a trend that seems likely to continue given the large CLO pipeline, a record number of open warehouses, and limited M&A activity. With most new deals offering no original issue discount, the opportunity to build par during the post-tariff volatility has passed.

The market has been digesting the European Commission’s proposals on reforming the securitization framework since they were unveiled in June. The proposals present a mixed picture for CLOs and key provisions on capital requirements for insurers are still to be formally revealed. While the draft legislation promises a streamlining of due diligence and reporting requirements, it would also reclassify European CLOs and potentially U.S. ones as public deals, and would increase transaction costs by requiring all deals to submit their transparency data to repositories.

The biggest capital benefits offered, even if in theory available to CLOs, would only be available to originator banks. The proposals do not mention the sole purpose test for risk retention, offering no respite from the uncertainty that has bedeviled the market since the European Supervisory Authorities’ surprise intervention at the end of March.

This publication has been prepared by Octus, Inc. or one of its affiliates (collectively, "Octus") and is being provided to the recipient in connection with a subscription to one or more Octus products. Recipient’s use of the Octus platform is subject to Octus Terms of Use or the user agreement pursuant to which the recipient has access to the platform (the “Applicable Terms”). The recipient of this publication may not redistribute or republish any portion of the information contained herein other than with Octus express written consent or in accordance with the Applicable Terms. The information in this publication is for general informational purposes only and should not be construed as legal, investment, accounting or other professional advice on any subject matter or as a substitute for such advice. The recipient of this publication must comply with all applicable laws, including laws regarding the purchase and sale of securities. Octus obtains information from a wide variety of sources, which it believes to be reliable, but Octus does not make any representation, warranty, or certification as to the materiality or public availability of the information in this publication or that such information is accurate, complete, comprehensive or fit for a particular purpose. Recipients must make their own decisions about investment strategies or securities mentioned in this publication. Octus and its officers, directors, partners and employees expressly disclaim all liability relating to or arising from actions taken or not taken based on any or all of the information contained in this publication. © 2025 Octus. All rights reserved. Octus(TM) and the Octus logo are trademarks of Octus Intelligence, Inc.